Consider RSV infant monoclonal antibody administration through April due to late RSV activity - March 25, 2026
The purpose of this communication is to notify CVP and CVFA providers that the Connecticut Department of Public Health is advising to consider continued administration of respiratory syncytial virus (RSV) to eligible infants for the prevention of severe RSV disease through April 30, 2026.